Donor T-cell-mediated pancytopenia after haploidentical hematopoietic stem cell transplant for severe combined immunodeficiency

Journal of Pediatric Hematology/Oncology

Volumn 31, Issue 2, 2009, Pages 148-150

  Bunin, Nancy ^a   Norris, Robin ^b   Paessler, Michele ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b NONE

Author keywords

GVHD; Hematopoietic stem cell transplant; SCID

Indexed keywords

CLARITHROMYCIN; ETHAMBUTOL; HYDROCORTISONE; METHYLPREDNISOLONE; PREDNISOLONE; RIFAMPICIN; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ARTICLE; ASSISTED VENTILATION; BONE MARROW BIOPSY; BONE MARROW CULTURE; CASE REPORT; CORYNEBACTERIUM INFECTION; DIARRHEA; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ENGRAFTMENT; ERYTHEMA; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LYMPHOCYTE COUNT; MALE; PANCYTOPENIA; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SEVERE COMBINED IMMUNODEFICIENCY; SKIN BIOPSY; T CELL DEPLETION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; GRAFT SURVIVAL; HAPLOTYPE; METHODOLOGY; PHYSIOLOGY; T LYMPHOCYTE; TRANSPLANTATION; TREATMENT OUTCOME;

GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; PANCYTOPENIA; SEVERE COMBINED IMMUNODEFICIENCY; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 60849118985     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181979c4a     Document Type: Article

References (13)

1. Buckley RH, Schiff SE, Schiff RI, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 1999;340:508-516.
2. Antoine C, Muller S, Cant A, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet. 2003;361:553-560.
3. Chaleff S, Otto M, Barfield RC, et al. A large-scale method for the selective depletion of αβ T lymphocytes from PBSC for allogeneic transplantation. Cytotherapy. 2007;9:746-754.
4. Rubocki RJ, Parsa JR, Hershfield MS, et al. Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency. Blood. 2001;97:809-811.
5. Haddad E, Le Deist F, Aucouturier P, et al. Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: a single-center study of 22 patients. Blood. 1999;94: 2923-2930.
6. Grogan TM, Broughton DD, Doyle WF. Graft-versus-host reaction (GVHR). A case report suggesting GVHR occurred as a result of maternofetal cell transfer. Arch Pathol. 1975;99: 330-334.
7. Dvorak CC, Sandford A, Fong A, et al. Maternal T-cell engraftment associated with severe hemophagocytosis of the bone marrow in untreated X-linked severe combined immunodeficiency. J Pediatr Hematol Oncol. 2008;30:396-400.
8. Thaler M, Shamiss A, Orgad S, et al. The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery. N Engl J Med. 1989;321:25-28.
9. Hara H, Ohdan H, Tashiro H, et al. Differential diagnosis between graft-versus-host disease and hemophagocytic syndrome after living-related liver transplantation by mixed lymphocyte reaction assay. J Invest Surg. 2004;17:197-202.
10. Slatter MA, Bhattacharya A, Abinun M, et al. Outcome of boost haemopoietic stem cell transplant for decreased donor chimerism or graft dysfunction in primary immunodeficiency. Bone Marrow Transplant. 2005;35:683-689.
11. Booth C, Ribeil JA, Audat F, et al. CD34 stem cell top-ups without conditioning after initial haematopoietic stem cell transplantation for correction of incomplete haematopoietic and immunological recovery in severe congenital immunodeficiencies. Br J Haematol. 2006;135:533-537.
12. Ratanatharathorn V, Ayash L, Reynolds C, et al. Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. Biol Blood Marrow Transplant. 2003;9: 505-511.
13. Canninga-van Dijk MR, van der Straaten HM, Fijnheer R, et al. Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease. Blood. 2004;104:2603-2606.